Copy to clipboard 
Acumed announced the acquisition of ExsoMed. The transaction enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to complex injuries.
“Demand for minimally invasive surgical devices continues to grow and the ExsoMed products are great additions to our minimally invasive offerings,” said Milton Torres, VP of Hand and Upper Extremity, Acumed. “ExsoMed’s innovative products are a natural fit for Acumed’s extensive portfolio of industry-first hand and wrist solutions. These products are designed to provide surgeons with in situ customization options to achieve optimal patient fit and restoration of function.”
Acumed’s selection of upper extremity fixation and specialty plates are now complemented by ExsoMed’s threaded nails, which offer minimally invasive solutions to treat fractures, fusions and late-stage arthritic conditions.
“We are thrilled by the addition of ExsoMed to the extensive Acumed portfolio of innovative upper extremity, lower extremity, CMF, tendon, ligament, and orthobiologics solutions to better serve our customers worldwide,” said Hjalmar Pompe van Meerdervoort, President, Acumed. “With Acumed’s experience and vast resources, we are excited to combine efforts with ExsoMed to accelerate the shift in the standard of care for hand fractures.”
ExsoMed products include:
INnate – ExsoMed’s solution for treating metacarpal fractures. INnate is an intramedullary threaded nail designed to provide surgeons with a treatment for metacarpal fractures through a simple, minimally invasive approach.
InFrame – Designed specifically for all types of phalanx fractures. The robust length offering of InFrame is intended to accurately fit the intramedullary canal and achieve bicortical bone purchase, creating stable fixation and precise reduction.
ArrowPhix – ExsoMed’s innovative arrow-shaped screw for functional variable angle DIP fusions. The related ArcPhix is an angled screw for strong, functional angle DIP fusions. Research has shown that when a patient’s distal interphalangeal joint is fused in a functional position, finger dexterity and grip strength improve over that of a patient with a straight, strength fusion.
“Patients, surgeons, and innovation have been the key drivers in all of ExsoMed’s business decisions,” said James Young Kim, Chief Marketing Officer, ExsoMed. “The culture, history, and ambitions of Acumed align so naturally for us at ExsoMed that this decision to join the growing Acumed family was never second-guessed. We are grateful for the opportunity to expand ExsoMed’s technologies utilizing Acumed’s vast resources and continuing to raise the standard of care in hand surgery.”
